Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-16,750
Closed -$481K 212
2019
Q2
$481K Hold
16,750
0.01% 146
2019
Q1
$704K Sell
16,750
-250
-1% -$8.99K 0.04% 131
2018
Q4
$529K Buy
+17,000
New +$632K 0.03% 131

Other funds holding AFMD

Bellevue Group's AFMD Position: Q3 2019 in Review

Bellevue Group sold out of Affimed (AFMD) in Q3 2019, closing a stake of 16,750 shares — an estimated $481K sold.

Bellevue Group first reported a position in AFMD in Q4 2018 and held it in 3 quarters. The position peaked at $704K in Q1 2019. 83 funds tracked by Wall St. Rank hold AFMD as of Q3 2019.

  • Bellevue Group reported no remaining Affimed position as of Q3 2019 after selling out during the quarter.
  • Bellevue Group sold 16,750 Affimed shares in Q3 2019, an estimated $481K.
  • Bellevue Group first reported a position in Affimed in Q4 2018 and held it in 3 quarters.
  • Bellevue Group's Affimed position peaked at $704K in Q1 2019.
  • 83 funds tracked by Wall St. Rank held Affimed as of Q3 2019.

Based on Bellevue Group's 13F filing for Q3 2019, filed 14 Nov 2019.